Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025)
Eton Pharmaceuticals (ETON) reported EBT Margin of 6.64% for Q4 2025, up 1103.0% on a YoY basis from 0.55% in Q4 2024, and up 176.33% sequentially from 8.7% in Q3 2025.
Eton Pharmaceuticals (ETON) EBT Margin (2019 - 2025) Analysis & Trends
Eton Pharmaceuticals (ETON) has 7 years of EBT Margin data on file, last reported at 6.64% in Q4 2025.
- For the quarter ending Q4 2025, EBT Margin rose 1103.0% year-over-year to 6.64%; the trailing twelve-month figure through Dec 2025 stood at 5.7% (up 406.0% YoY), and the FY2025 full-year result was 5.7%, up 406.0% from the prior year.
- EBT Margin climbed to 6.64% in Q4 2025, from 8.7% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 43.0% in Q1 2021 to a low of 786.32% in Q3 2021.
- A 5-year average of 60.6% and a median of 8.69% in 2025 frame the typical range for EBT Margin.
- Peak annual rise in EBT Margin reached 2358427 bps in 2021, while the deepest fall reached 25621628 bps in 2021.
- Tracing ETON's EBT Margin over 5 years: stood at 17.05% in 2021, then tumbled by 37 bps to 10.73% in 2022, then sank by 163 bps to 6.74% in 2023, then jumped by 35 bps to 4.39% in 2024, then surged by 251 bps to 6.64% in 2025.
- Business Quant data shows ETON's EBT Margin at 6.64% in Q4 2025, 8.7% in Q3 2025, and 13.31% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 10.97% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 33.51% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -41.57% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 40.73% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -7.05% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 30.30% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.35% |
| 10 | Eton Pharmaceuticals | 1.19 Bn | 1.16 Bn | 13.10 Mn | 6.64% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.64% |
| Sep 30, 2025 | -8.70% |
| Jun 30, 2025 | -13.31% |
| Mar 31, 2025 | -8.67% |
| Dec 31, 2024 | -4.39% |
| Sep 30, 2024 | 4.85% |
| Jun 30, 2024 | -32.92% |
| Mar 31, 2024 | -10.18% |
| Dec 31, 2023 | -6.74% |
| Sep 30, 2023 | -8.24% |
| Jun 30, 2023 | 38.00% |
| Mar 31, 2023 | -50.15% |
| Dec 31, 2022 | 10.73% |
| Sep 30, 2022 | -60.90% |
| Jun 30, 2022 | -31.16% |
| Mar 31, 2022 | -244.94% |
| Dec 31, 2021 | 17.05% |
| Sep 30, 2021 | -786.32% |
| Jun 30, 2021 | -65.73% |
| Mar 31, 2021 | 43.00% |